US Broker Ratings

Health Catalyst, Inc (HCAT) Stock Analysis: Exploring a 45% Potential Upside Amidst Challenging Metrics

Health Catalyst, Inc. (NASDAQ: HCAT), a prominent player in the healthcare information services sector, is currently navigating a complex landscape with a blend of opportunities and challenges. Headquartered in South..

Zhengye Biotechnology Holding L (ZYBT): An Investor Outlook Amidst a Steep 52-Week Price Fluctuation

Zhengye Biotechnology Holding Limited (ZYBT), a key player in the healthcare sector, specializes in the development of veterinary vaccines. With a market cap of $102.37 million, this Chinese company has..

Viemed Healthcare, Inc. (VMD) Investor Outlook: Exploring a Promising 92% Upside Potential

Viemed Healthcare, Inc. (NASDAQ: VMD), a prominent player in the U.S. healthcare sector, is making waves with its focus on post-acute respiratory care and home medical equipment. As investors eye..

Quantum-Si Incorporated (QSI) Stock Analysis: Exploring a Potential 109.56% Upside with Innovative Protein Sequencing Technology

Investors with an eye toward cutting-edge healthcare innovations may find Quantum-Si Incorporated (NASDAQ: QSI) an intriguing prospect. Specializing in Next Generation Protein Sequencing (NGPS), Quantum-Si is pioneering advancements in the..

TruBridge, Inc. (TBRG) Stock Report: Navigating Growth in Healthcare IT with a Forward P/E of 10.18

TruBridge, Inc. (TBRG), a prominent player in the healthcare information services sector, is making waves with its comprehensive suite of solutions aimed at enhancing operational efficiencies for community hospitals and..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Unpacking a Potential 438% Upside

Arcturus Therapeutics Holdings Inc. (ARCT), a San Diego-based biotechnology company, has caught the attention of investors with a remarkable potential upside of 438.69%. Specializing in infectious disease vaccines and therapeutics..

Benitec Biopharma Inc. (BNTC) Investor Outlook: Unpacking a Potential 105% Upside

For investors with an eye on the biotech sector, Benitec Biopharma Inc. (NASDAQ: BNTC) presents a compelling opportunity. With a market capitalization of $425.99 million, this clinical-stage biotechnology company based..

Aura Biosciences, Inc. (AURA) Stock Analysis: A Biotech with Over 200% Upside Potential

Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company, is capturing the attention of investors with its innovative approach to treating solid tumors. Headquartered in Boston, Massachusetts, Aura is at..

Candel Therapeutics, Inc. (CADL) Stock Analysis: Unveiling a 271% Potential Upside in Biotech

Candel Therapeutics, Inc. (NASDAQ: CADL), a clinical-stage biopharmaceutical company based in Needham, Massachusetts, is capturing the attention of investors with a striking potential upside of 271%. Specializing in the development..

ClearPoint Neuro Inc. (CLPT) Stock Analysis: Exploring a 105.97% Potential Upside in the Medical Device Sector

ClearPoint Neuro Inc. (NASDAQ: CLPT) is making waves in the healthcare sector, particularly within the medical device industry. The company, headquartered in Solana Beach, California, is focused on pioneering minimally..

National Research Corporation (NRC) Stock Analysis: High ROE Amidst Low Revenue Growth

National Research Corporation (NASDAQ: NRC), a significant player in the Health Information Services industry, stands out in the healthcare sector for its robust suite of analytics and insights solutions. As..

Anbio Biotechnology (NNNN) Stock Analysis: Navigating Challenges in the Medical Instruments Industry

Anbio Biotechnology (NNNN), a relatively young player in the medical instruments and supplies industry, has rapidly made a name for itself by providing in vitro diagnostics (IVD) products across global..

Exxon Mobil Corporation (XOM) Stock Analysis: Exploring a 9.44% Upside and Robust Dividend Yield

Exxon Mobil Corporation (XOM), a titanic presence in the energy sector, continues to capture investor attention with its strategic positioning in the integrated oil and gas industry. With a market..

Alpha Teknova, Inc. (TKNO) Stock Analysis: Analysts See Significant 87% Upside Potential

Alpha Teknova, Inc. (NASDAQ: TKNO) stands at an intriguing juncture for investors, offering a blend of growth prospects and challenges that come with its positioning in the healthcare sector. With..

NeoGenomics, Inc. (NEO) Stock Analysis: A Promising Investment with Over 11% Potential Upside

Investors seeking opportunities in the healthcare sector might find NeoGenomics, Inc. (NASDAQ: NEO) an intriguing prospect. This U.S.-based company, with a market capitalization of $1.56 billion, operates an extensive network..

Harrow, Inc. (HROW) Stock Analysis: Eyeing a 77% Potential Upside in the Healthcare Sector

Harrow, Inc. (NASDAQ: HROW) is capturing attention in the healthcare sector with a significant 77.54% potential upside, according to analysts’ target price projections. As an eyecare pharmaceutical company, Harrow specializes..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 27% Potential Upside in Non-Opioid Pain Management

Pacira BioSciences, Inc. (PCRX) has carved a niche for itself in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. The company, headquartered in Tampa, Florida, focuses..

AdaptHealth Corp. (AHCO) Stock Report: Exploring a 35.90% Potential Upside and Analyst Consensus

AdaptHealth Corp. (NASDAQ: AHCO), a prominent player in the healthcare sector specializing in medical devices, has garnered significant attention from investors due to its promising growth potential. Headquartered in Plymouth..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Unpacking the 33.7% Revenue Growth in the Medical Device Sector

For investors eyeing the healthcare sector, particularly the burgeoning medical devices industry, Establishment Labs Holdings Inc (NASDAQ: ESTA) presents a compelling case with its impressive year-over-year revenue growth of 33.7%...

Neogen Corporation (NEOG) Stock Report: Navigating a Potential 37.95% Upside in the Diagnostics & Research Sector

Neogen Corporation (NASDAQ: NEOG), a key player in the Healthcare sector’s Diagnostics & Research industry, is capturing the attention of individual investors with its intriguing potential upside of 37.95%. Despite..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds